Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin E

What does the research say about Vitamin E?

8 health outcomes synthesised

Vitamin E has been studied across 8 health outcomes, including liver health, inflammation, pain, and antioxidant markers. The strongest evidence—from 5 studies—supports a small beneficial effect on reducing aspartate aminotransferase (AST) levels in patients with NAFLD/NASH/MASLD, with doses typically ranging from 300 to 1000 IU per day. Additional moderate-strength evidence from 4 studies indicates similar benefits for alanine aminotransferase (ALT) reduction in NAFLD patients.

Strongest evidence

Four outcomes have moderate evidence strength. For liver health, 3 of 5 studies found vitamin E reduced AST levels (small effect, 300–1000 IU/day), and all 4 studies on ALT reported beneficial effects (small to moderate, 400–1000 IU/day) in patients with NAFLD/NASH. Both effects typically appear within 8–12 weeks. For inflammation, 3 out of 3 studies showed reductions (effect sizes mixed, from small to large), with doses around 335 mg/day in one RCT. Pain reduction was reported in 3 of 3 studies (small effect, diverse populations including fibromyalgia and carpal tunnel syndrome).

Mixed or weaker evidence

Four outcomes have low evidence strength. Vitamin E levels: 1 of 3 studies found lower levels in vitiligo patients, but this is observational and does not support supplementation. Sperm morphology: 1 of 3 studies found a moderate improvement at 300 mg/day for 90 days, but two studies were neutral. Malondialdehyde (oxidative stress): 1 of 3 studies found a large reduction in epilepsy patients, but two were neutral. TNF-α (inflammation marker): 1 of 3 studies found a small reduction in NASH patients, while two were neutral. All low-evidence outcomes are limited by small sample sizes and frequent lack of statistical significance.

Effective dose patterns

Across outcomes with moderate evidence, effective doses converge on 300–1000 IU/day of vitamin E (often as alpha-tocopherol). For liver enzymes, 400–1000 IU/day is common; for inflammation and pain, doses around 335–400 IU/day appear in individual studies. No consistent dose emerged for low-evidence outcomes.

Population insights

The most robust evidence comes from patients with non-alcoholic fatty liver disease (NAFLD/NASH/MASLD). Other studied groups include gastrointestinal surgery patients, older women with sarcopenia, fibromyalgia patients, and men with idiopathic infertility. Generalization to healthy populations is limited.

Notable caveats

Many syntheses note publication bias—positive results are more likely to be published. The evidence base is small for most outcomes (only 3–5 studies), and several studies used vitamin E in combination with other supplements, making it difficult to isolate its effects. Many individual studies did not reach statistical significance, suggesting true effects may be smaller than the predominant direction indicates.

Frequently asked

  • What is Vitamin E good for according to research?
    Research suggests vitamin E may have beneficial effects on liver health, particularly reducing liver enzymes (AST and ALT) in people with non-alcoholic fatty liver disease (NAFLD/NASH). Moderate evidence from 5 studies on AST and 4 studies on ALT supports a small to moderate effect. There is also moderate evidence for reducing inflammation and pain in certain clinical populations, though effect sizes vary.
  • What dose of Vitamin E is typically used in studies?
    Across studies with moderate evidence, typical doses range from 300 to 1000 IU per day (often as alpha-tocopherol). For liver enzyme reduction, the most common range is 400–1000 IU/day. For inflammation and pain, doses around 335–400 IU/day have been used. Doses are usually taken for 8–12 weeks to see effects.
  • Who benefits most from Vitamin E based on research?
    The strongest evidence comes from studies on patients with non-alcoholic fatty liver disease (NAFLD/NASH/MASLD), where vitamin E showed consistent benefits for reducing liver enzymes. Other populations with limited evidence include people with fibromyalgia or carpal tunnel syndrome (for pain), and men with certain types of infertility (for sperm morphology). Available research does not confirm benefits in healthy individuals without specific conditions.
  • Are there caveats or limitations in the research on Vitamin E?
    Yes. Many syntheses cite publication bias—positive results are more likely to be published. Most outcomes are supported by only 3–5 studies, and many individual trials did not reach statistical significance, suggesting true effects may be smaller than reported. Several studies used vitamin E in combination with other supplements, making it hard to attribute benefits solely to vitamin E. The evidence base is small and preliminary for many outcomes.
  • Does Vitamin E help with liver health?
    Moderate evidence indicates vitamin E can reduce two key liver enzymes—aspartate aminotransferase (AST) and alanine aminotransferase (ALT)—in patients with NAFLD/NASH. Of 5 studies on AST, 3 showed a small beneficial effect; all 4 studies on ALT showed a beneficial effect (small to moderate). Effects typically occur after 8–12 weeks of supplementation with doses of 300–1000 IU/day.
  • Does Vitamin E help with pain?
    Three studies reported beneficial effects of vitamin E on pain reduction in patients with fibromyalgia, carpal tunnel syndrome, and oral mucosal/periodontal diseases. The predominant effect size was small, and the evidence is moderate in strength. However, most studies used vitamin E in combination with other nutrients, limiting the ability to isolate its specific effect. The evidence base is small (3 studies).

Most-studied combinations with Vitamin E

most supplement research is combination research
  • Low evidence
    withVitamin CforReduced Pain· 3 studies

    Across 3 studies, all reported beneficial effects of the Vitamin E and Vitamin C combination on pain reduction, with effect sizes ranging from small to moderate and all findings statistically significant. Compared to Vitamin C alone (moderate evidence, small effect), the combination shows a similar directional benefit but the limited number of studies precludes a definitive comparison. The median study duration was 60 days (reported in 1 of 3 studies). No form data were reported for either substance.

  • Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $64.39
    In
    Vitacost
    $64.39
    In
    Vitamin Shoppe
    $67.99
    In
  • CLA80 Femme

    By Allmax

    4.4 (132 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $11.99
    In
    iHerb
    $11.99
    In
    Vitacost
    $9.79
    In
    Vitamin Shoppe
    $-
    Out
  • Super 1 Daily

    By Carlson

    4.7 (20 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $54.40
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $28.34
    In
    Vitacost
    $28.34
    In
    Vitamin Shoppe
    $-
    Out
  • Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $42.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Phosphatidylserine

    By Metagenics

    5 (1 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $82.50
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
Back to top